We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Justice, HHS’ OIG End Inquiries Into Boston Sci CRM Section
Justice, HHS’ OIG End Inquiries Into Boston Sci CRM Section
July 29, 2011
As two investigations into Boston Scientifics’ Cardiac Rhythm Management (CRM) division come to a close, the devicemaker is preparing to defend itself against safety allegations from the FDA.